BRPI0812306A2 - Composição útil para a prevenção do efeito adverso devido ao uso de agonistas ppar-gama - Google Patents

Composição útil para a prevenção do efeito adverso devido ao uso de agonistas ppar-gama

Info

Publication number
BRPI0812306A2
BRPI0812306A2 BRPI0812306-3A2A BRPI0812306A BRPI0812306A2 BR PI0812306 A2 BRPI0812306 A2 BR PI0812306A2 BR PI0812306 A BRPI0812306 A BR PI0812306A BR PI0812306 A2 BRPI0812306 A2 BR PI0812306A2
Authority
BR
Brazil
Prior art keywords
ppar
agonists
prevention
range
adverse effect
Prior art date
Application number
BRPI0812306-3A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Menotti Calvani
Stefania D Iddio
Paola Benatti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of BRPI0812306A2 publication Critical patent/BRPI0812306A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
BRPI0812306-3A2A 2007-05-24 2008-04-28 Composição útil para a prevenção do efeito adverso devido ao uso de agonistas ppar-gama BRPI0812306A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07108801 2007-05-24
PCT/EP2008/055171 WO2008141897A1 (en) 2007-05-24 2008-04-28 Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists

Publications (1)

Publication Number Publication Date
BRPI0812306A2 true BRPI0812306A2 (pt) 2014-11-25

Family

ID=38668873

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812306-3A2A BRPI0812306A2 (pt) 2007-05-24 2008-04-28 Composição útil para a prevenção do efeito adverso devido ao uso de agonistas ppar-gama

Country Status (10)

Country Link
US (1) US20100305204A1 (enExample)
EP (1) EP2162127A1 (enExample)
JP (1) JP2010527952A (enExample)
KR (1) KR20100017460A (enExample)
CN (1) CN101677983B (enExample)
AU (1) AU2008253134A1 (enExample)
BR (1) BRPI0812306A2 (enExample)
CA (1) CA2687154A1 (enExample)
MX (1) MX2009012429A (enExample)
WO (1) WO2008141897A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940884B (zh) * 2012-11-19 2013-11-06 上海市肿瘤研究所 一种肝癌细胞的抑制剂及其在抑制肿瘤生长方面的应用
KR102072075B1 (ko) * 2018-06-21 2020-01-31 울산과학기술원 TRIM25을 유효성분으로 함유하는 PPARγ 분해용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1133010B (it) * 1980-05-15 1986-07-09 Sigma Tau Ind Farmaceuti Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
DE69942672D1 (de) * 1998-12-17 2010-09-23 Mindset Biopharmaceuticals Usa Verbesserung der geistigen fähigkeiten durch die steigerung der insulin-empfindlichkeit des gehirns
CN1812988A (zh) * 2003-05-13 2006-08-02 斯索恩有限公司 制备噻唑烷二酮衍生物的方法及其化合物
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20060252670A1 (en) * 2004-10-14 2006-11-09 Intercept Pharmaceuticals Inc. Method of reducing drug-induced adverse side effects in a patient

Also Published As

Publication number Publication date
CA2687154A1 (en) 2008-11-27
AU2008253134A1 (en) 2008-11-27
CN101677983A (zh) 2010-03-24
US20100305204A1 (en) 2010-12-02
EP2162127A1 (en) 2010-03-17
JP2010527952A (ja) 2010-08-19
WO2008141897A1 (en) 2008-11-27
CN101677983B (zh) 2012-12-26
MX2009012429A (es) 2009-12-09
KR20100017460A (ko) 2010-02-16

Similar Documents

Publication Publication Date Title
BRPI0821165A2 (pt) Uso de uma composição
BRPI0813381A2 (pt) Uso de líquidos iônicos para melhorar as propriedades de composições lubrificantes
CR20140154A (es) Compuestos para inhibir la progresión mitotica
BRPI0720993A2 (pt) métodos de uso para análogos de ciclopamina
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
BRPI0908131A2 (pt) Uso de vídeo com disparadores para identificação de conteúdo anterativo
BRPI1009155A2 (pt) dispositivo de colagem para toras de material enrolado similar à manta
BRPI0818041A2 (pt) Uso de uma composição de poliamida de moldagem para o revestimento interno de tubulações
PT3812360T (pt) Compostos de monoclorotrifluoropropeno e composições e métodos utilizando os mesmos
BRPI0811612A2 (pt) Composições farmacêuticas que contêm agonista ppardelta
EP2223992A4 (en) LUBRICANT COMPOSITION
EP2119761A4 (en) LUBRICANT COMPOSITION
EP2141220A4 (en) LUBRICANT COMPOSITIONS
BRPI0818079A2 (pt) composição de lipideo
BRPI0815947A2 (pt) misturas de gipsita para formar sólidos
BRPI0921399A2 (pt) composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante
BRPI1014914A2 (pt) Composição contendo trehalulose, sua preparação e uso
BRPI0812166A2 (pt) Composições úteis para reduzir nefrotoxicidade e métodos de uso das mesmas
EP2154231A4 (en) LUBRICANT COMPOSITION
BR112012004173A2 (pt) "composto, composição, método para preparar uma composição, e, uso de um composto"
DK2280706T3 (da) Lipasa-aktiverende lipoproteinsammensætninger omfattende benzenderivater
BRPI0819566A2 (pt) "composições antissépticas para tecidos"
BRPI0925002A2 (pt) uso de uma composição para a prevenção de diarréia
BRPI0916575A2 (pt) composição de graxa lubrificante, e, uso de uma composição de graxa lubrificante

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.